Pediatric mesenchymal stromal cells therapy: an update

Area of Science:

• Regenerative Medicine
• Cell Biology
• Pediatric Therapeutics

Background:

• Mesenchymal stromal cells (MSCs) are a heterogeneous cell population.
• No single definitive marker exists for MSC identification.
• MSCs are characterized by adherence to plastic, spindle-like morphology, and trilineage plasticity (bone, cartilage, fat differentiation).

Purpose of the Study:

• To review recent advancements in Mesenchymal Stromal Cell (MSC) therapy within the field of Pediatrics.
• To clarify the nomenclature and characteristics of MSCs, preferring 'multipotent stromal cells' over 'mesenchymal stem cells'.
• To highlight the therapeutic potential of MSCs in pediatric applications.

Main Methods:

• Literature review of recent studies on MSC therapy in pediatrics.
• Analysis of MSC characteristics, including identification markers and differentiation capabilities.
• Discussion on the advantages of the term 'multipotent stromal cells' for accurate definition.

Main Results:

• Mesenchymal stromal cells (MSCs) exhibit multipotent differentiation capabilities.
• The term 'multipotent stromal cells' is preferred to encompass cells with true stem cell properties.
• Recent research indicates growing applications of MSC therapy in pediatric contexts.

Conclusions:

• Mesenchymal stromal cells (MSCs) hold significant therapeutic potential in pediatrics.
• Accurate identification and characterization of MSCs are crucial for effective therapy.
• Further research into pediatric MSC applications is warranted to optimize treatment strategies.